In Vitro Activities of Garenoxacin (BMS-284756) against Haemophilus influenzae Isolates with Different Fluoroquinolone Susceptibilities

The in vitro activity of garenoxacin (BMS-284756) against 62 clinical Haemophilus influenzae isolates with different fluoroquinolone susceptibilities was determined by the microdilution susceptibility testing method and compared with the activities of other oral quinolones and nonquinolone oral anti...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Pérez-Vázquez, María, Román, Federico, Aracil, Belen, Cantón, Rafael, Campos, José
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC253788/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14576114/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.11.3539-3541.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!